Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

194 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Recruiting

Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

NCT05904106

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Universitätsklinikum Essen Essen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Aachen Aachen, Germany
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Klinikum Chemnitz gGmbH Chemnitz, Germany
View all 18 locations
View Trial Details
Recruiting

Risk Stratification and MRD-driven Maintenance for MM After ASCT

NCT06697483

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Fuxing Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
View Trial Details
Recruiting

Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer

NCT05965479

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +13 more
Locations
  • Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital Guildford, Surrey, United Kingdom
  • University Hospitals Coventry and Warwickshire, University Hospital Coventry Coventry, Warwickshire, United Kingdom
  • Belfast Health and Social Care Trust, Belfast City Hospital Belfast, United Kingdom
  • Cambridge University Hospital NHS Foundation Trust, Addenbrookes Hospital Cambridge, United Kingdom
View all 14 locations
View Trial Details

Related conditions